Fig. 4From: Timing gone awry: distinct tumour suppressive and oncogenic roles of the circadian clock and crosstalk with hypoxia signalling in diverse malignanciesCircadian dysregulation drives malignant progression. Differential expression analyses are performed between 4th and 1st quartile patients determined using ClockLoss or ClockGain. a Venn diagrams illustrate the number of differentially expressed genes (DEGs) and their overlapping patterns in five cohorts. Numbers in parentheses represent DEGs. Table inset depicts the number of genes that are found to be in common in five, > four and > three cancer types. Overlap between common ClockLoss and ClockGain genes are also depicted. Enriched b GO terms, c KEGG ontologies and d transcription factor binding associated with DEGsBack to article page